Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR

Human Molecular Genetics

Volumn 19, Issue 17, 2010, Pages 3320-3331

  Siegel, Nicol ^a   Rosner, Margit ^a   Unbekandt, Mathieu ^b   Fuchs, Christiane ^a   Slabina, Nina ^a   Dolznig, Helmut ^a   Davies, Jamie A ^b   Lubec, Gert ^a   Hengstschläger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; LAMININ; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; SMALL INTERFERING RNA; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR PAX2; TUBERIN; UVOMORULIN; WT1 PROTEIN;

AMNION FLUID; AMNIOTIC FLUID STEM CELL; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CHIMERA; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY DEVELOPMENT; KIDNEY PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

AMNIOTIC FLUID; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MICE; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

MAMMALIA; MURINAE;

EID: 77955412174     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq236     Document Type: Article

References (47)

1. Pennings, G. (2007) The ethics of using embryos in research. Reprod. Biomed. Online, 14, 92-97.
2. Aboushwareb, T. and Atala, A. (2008) Stem cells in urology. Nat. Clin. Pract. Urol., 5, 621-631.
3. Siegel, N., Rosner, M., Hanneder, M., Valli, A. and Hengstschläger, M. (2007) Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev., 3, 256-264.
4. Perin, L., Sedrakyan, S., Da Sacco, S. and De Filippo, R. (2008) Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol., 86, 85-99.
5. Cananzi, M., Atala, A. and DeCoppi, P. (2009) Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod. Biomed. Online, 18, 17-27.
6. Prusa, A.R., Marton, E., Rosner, M., Bernaschek, G. and Hengstschläger, M. (2003) Oct4 expressing cells in human amniotic fluid: a new source for stem cell research? Hum. Reprod., 18, 1489-1493.
7. in t'Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., Noort, W.A., Claas, F.H.J., Willemze, R., Fibbe, E.E. and Kanhai, H.H.H. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 102, 1548-1549.
8. Prusa, A.R., Marton, E., Rosner, M., Bettelheim, D., Lubec, G., Pollak, A., Bernaschek, G. and Hengstschläger, M. (2004) Neurogenic cell in human amniotic fluid. Am. J. Obstet. Gynecol., 191, 309-314.
9. Tsai, M-S., Lee, J-L., Chang, Y-J. and Hwang, M. (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum. Reprod., 19, 1450-1456.
10. Karlmark, K.R., Freilinger, A., Marton, E., Rosner, M., Lubec, G. and Hengstschläger, M. (2005) Activation of ectopic Oct4 and Rex-1 promoters in human amniotic fluid cells. Int. J. Mol. Med., 16, 987-992.
11. Kim, J., Lee, Y., Kim, H., Hwang, K.J., Kwon, H.C., Kim, S.K., Cho, D.J., Kang, S.G. and You, J. (2007) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif., 40, 75-90.
12. Kolambkar, Y.M., Peister, A., Soker, S., Atala, A. and Guldberg, R.E. (2007) Chondrogenic differentiation of amniotic fluid-derived stem cells. J. Mol. Histol., 38, 405-413.
13. Perin, L., Giuliani, S., Jin, D., Sedrakyan, S., Carraro, G., Habibian, R., Warburton, D., Atala, A. and De Filippo, R.E. (2007) Renal differentiation of amniotic fluid stem cells. Cell Prolif., 40, 936-948.
14. Ditadi, A., de Coppi, P., Picone, O., Gautreau, L., Smati, R., Six, E., Bonhomme, D., Ezino, S., Frydman, R., Cavazzano-Calvo, H. and Andre-Schmutz, I. (2009) Human and murine amniotic fluid c-Kit+Lincells display hematopoietic activity. Blood, 113, 3953-3960.
15. De Coppi, P., Bartsch, G., Siddiqui, M.M., Xu, T., Santos, T.X., Perin, L., Mostoslavsky, G., Serre, A.C., Snyder, E.Y., Yoo, J.J. et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol., 25, 100-106.
16. Valli, M., Rosner, M., Fuchs, C., Siegel, N., Bishop, C.E., Dolznig, H., Mädel, U., Feichtinger, W., Atala, A. and Hengstschläger, M. (2010) Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene, 29, 966-977.
17. Unbekandt, M. and Davies, J.A. (2010) Dissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues. Kidney Int., 77, 407-416.
18. Rosner, M., Siegel, N., Fuchs, C., Slabina, N., Dolznig, H. and Hengstschläger, M. (2010) Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat. Protoc., 5, 1081-1095.
19. Wullschleger, S., Loewith, R. and Hall, M. (2006) TOR signaling in growth and metabolism. Cell, 124, 471-484.
20. Dann, S.G., Selvaraj, A. and Thomas, G. (2007) mTOR complex 1-S6K1 signaling: at the cross roads of obesity, diabetes and cancer. Trends Mol. Med., 13, 252-259.
21. Yang, Q. and Guan, L. (2007) Expanding mTOR signaling. Cell Res., 17, 666-681.
22. Guertin, D.A. and Sabatini, D.M. (2007) Defining the role of mTOR in cancer. Cancer Cell, 12, 9-22.
23. Rosner, M., Hanneder, M., Siegel, N., Valli, A., Fuchs, C. and Hengstschläger, M. (2008) The mTOR pathway and its role in human genetic diseases. Rev. Mutat. Res., 659, 284-292.
24. Davies, J.A. (1994) Control of calbindin-D28K expression in developing mouse kidney. Dev. Dyn., 199, 45-51.
25. Bouchard, M., Souabni, A., Mandler, M., Neubüser, A. and Busslinger, M. (2002) Nephric lineage specification by Pax2 and Pax8. Genes Dev., 16, 2958-2970.
26. Cho, E.A., Patterson, L.T., Brookhiser, W.T., Mah, S., Kintner, C. and Dressler, G.R. (1998) Differential expression and function of cadherin-6 during renal epithelium development. Development, 125, 803-812.
27. Sorokin, L.M., Pausch, F., Durbeej, M. and Ekblom, P. (1997) Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. Dev. Dyn., 210, 446-462.
28. Davies, J.A., Ladomery, M., Hohenstein, P., Miachel, L., Shafe, A., Spraggon, L. and Hastie, N. (2004) Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum. Mol. Genet., 13, 235-246.
29. Niksic, M., Slight, J., Sanford, J.R., Caceres, J.F. and Hastie, N. (2004) The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum. Mol. Genet., 13, 463-471.
30. Winbanks, C.E., Grimwood, L., Gasser, A., Darby, I.A., Hewitson, T.D. and Becker, G.J. (2007) Role of the phosphatidylinositol 3-kinase and mTOR pathways in the regulation of renal fibroblast function and differentiation. Int. J. Biochem. Cell Biol., 39, 206-219.
31. Vollenbröker, B., George, B., Wolfgart, M., Saleem, M.A., Pavenstädt, H. and Weide, T. (2009) mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes. Am. J. Physiol. Renal Physiol., 296, 418-426.
32. Letavernier, E., Bruneval, P., Vandermeersch, S., Perez, J., Mandet, C., Belair, M.F., Haymann, J.P., Legendre, C. and Baud, L. (2009) Sirolimus interacts with pathways essential for podocyte integrity. Nephrol. Dial. Transplant., 24, 630-638.
33. Johnson, M.W., Kerfoot, C., Bushnell, T., Li, M. and Vinters, H.V. (2001) Hamartin and tuberin expression in human tissues. Mod. Pathol., 14, 202-210.
34. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J-H., Hus, P.P., Bagley, A.F., Markhard, A.L. and Sabatini, D.M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell, 22, 159-168.
35. Rosner, M. and Hengstschläger, M. (2008) Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum. Mol. Genet., 17, 2934-2948.
36. Bussolati, B., Tetta, C. and Camussi, G. (2008) Contribution of stem cells to kidney repair. Am. J. Nephrol., 28, 813-822.
37. Murray, P., Camussi, G., Davies, J., Edgar, D., Hengstschläger, M., Kenny, S., Remuzzi, G. and Werner, C. (2007) The KIDSTEM European research training network. Developing a stem cell based therapy to replace nephrons lost through reflux nephropathy. Organogenesis, 3,1-4.
38. Morigi, M., Imberti, B., Zoja, C., Corna, D., Tomasoni, S., Abbate, M., Rottoli, D., Angioletti, S., Benigni, A., Perico, N., Alison, M. and Remuzzi, G. (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol., 15, 1794-1804.
39. Yokoo, T., Ohashi, T., Shen, J.S., Sakurai, K., Miyazaki, Y., Utsunomiya, Y., Takahashi, M., Terada, Y., Eto, Y., Kawamura, T., Osumi, N. and Hosoya, T. (2005) Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc. Natl Acad. Sci. USA, 102, 3296-3300.
40. Bussolati, B., Bruno, S., Grange, C., Buttiglieri, S., Deregibus, M.C., Cantino, D. and Camussi, G. (2005) Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol., 166, 545-555.
41. Steenhard, B.M., Isom, K.S., Cazcarro, P., Dunmore, J.H., Godwin, A.R., St John, P.L. and Abrahamson, D.L. (2005) Integration of embryonic stem cells in metanephric kidney organ culture. J. Am. Soc. Nephrol., 16, 1623-1631.
42. Bruce, S.J., Rea, R.W., Steptoe, A.L., Busslinger, M., Bertram, J.F. and Perkins, A.C. (2007) In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation, 75, 337-349.
43. Siegel, N., Valli, A., Fuchs, C., Rosner, M. and Hengstschläger, M. (2009) Induction of mesenchymal/epithelial marker expression in human amniotic fluid stem cells. Reprod. Biomed. Online, 19, 838-846.
44. Maherali, N. and Hochedlinger, K. (2008) Induced pluripotency of mouse and human somatic cells. Cold Spring Harb. Symp. Quant. Biol., 73, 157-162.
45. Rosner, M., Hofer, K., Kubista, M. and Hengstschläger, M. (2003) Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene, 22, 4786-4798.
46. Grobstein, C. (1956) Trans-filter induction of tubules in mouse metanephrogenic mesenchyme. Exp. Cell. Res., 10, 424-440.
47. Rosner, M., Freilinger, A., Hanneder, M., Fujita, N., Lubec, G., Tsuruo, T. and Hengstschläger, M. (2007) p27 localization depends on the tumor suppressor protein tuberin. Hum. Mol. Genet., 16, 1541-1556.